Araki, E., Yamashita, S., Arai, H., Yokote, K., Satoh, J., Inoguchi, T., . . . Ishibashi, S. (2019). Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52‐week data from the PROVIDE study. Diabetes Obes Metab.
Style de citation ChicagoAraki, Eiichi, et al. "Efficacy and Safety of Pemafibrate in People With Type 2 Diabetes and Elevated Triglyceride Levels: 52‐week Data From the PROVIDE Study." Diabetes Obes Metab 2019.
Style de citation MLAAraki, Eiichi, et al. "Efficacy and Safety of Pemafibrate in People With Type 2 Diabetes and Elevated Triglyceride Levels: 52‐week Data From the PROVIDE Study." Diabetes Obes Metab 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.